Industry: Biopharmaceutical Region: Europe Deal Price:US $1 million Deal Method: Equity investment
The company is licensed to manufacture investigational medicinal products and has extensive experience in the manufacture of investigational medicinal products.
Details: The company is a leading European manufacturer of infusion drugs, focusing on developing patient-specific infusion solutions, working closely with clinics, medical institutions, nursing homes, pharmacies, etc., to provide patients with all state-approved oncology drugs, antibiotics, assistions, etc.
The company's infusion solutions meet the highest Standards in Europe and are made entirely from state-approved medicinal products in advanced dust-free laboratories and under sterile conditions. Emphasis is placed on staff training and strict monitoring of production conditions, including pressure, humidity, pathogen load, etc.
The company is licensed to manufacture clinical investigational medicinal products and has extensive experience in the manufacture of clinical investigational medicinal products.
Cooperation intention
The company's shareholders plan to sell all their shares. If you are interested in acquiring the company, please contact us.